For citations:
Karateev A.E., Nasonov E.L., Glukhova S.I., Barakat A.A., Gibadullina R.L., Ageeva E.A., Fedorova O.S., Timofeeva T.S., Mikhailova G.R., Nasonova A.E. Evaluation of efficacy and safety of long-term use of amtolmetin guacil in rheumatic diseases: results of a 9-month observational AURORA study (Amtolmetin guacil: allRussian Register for Osteoarthritis, Rheumatoid arthritis and Ankylosing spondylitis). Rheumatology Science and Practice. 2019;57(1):66-74. (In Russ.) https://doi.org/10.14412/1995-4484-2019-66-74